Moore N - Search Results

1

Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costs.

Noize P, Bénard-Laribière A, Aulois-Griot M, Moore N, Miremont-Salamé G, Haramburu F. Noize P, et al. Among authors: moore n. Am J Clin Dermatol. 2010;11(2):131-6. doi: 10.2165/11530160-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20141234

2

Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.

Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Bégaud B. Moore N, et al. Br J Clin Pharmacol. 1997 Nov;44(5):513-8. doi: 10.1046/j.1365-2125.1997.00615.x. Br J Clin Pharmacol. 1997. PMID: 9384470 Free PMC article.

3

Frequency and cost of serious adverse drug reactions in a department of general medicine.

Moore N, Lecointre D, Noblet C, Mabille M. Moore N, et al. Br J Clin Pharmacol. 1998 Mar;45(3):301-8. doi: 10.1046/j.1365-2125.1998.00667.x. Br J Clin Pharmacol. 1998. PMID: 9517375 Free PMC article.

4

The link between sunshine and phototoxicity of sparfloxacin.

Pierfitte C, Royer RJ, Moore N, Bégaud B. Pierfitte C, et al. Among authors: moore n. Br J Clin Pharmacol. 2000 Jun;49(6):609-12. doi: 10.1046/j.1365-2125.2000.00212.x. Br J Clin Pharmacol. 2000. PMID: 10848726 Free PMC article.

5

Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.

Moore N, Verschuren X, Montout C, Callens J, Kong SX, Bégaud B. Moore N, et al. Therapie. 2000 Jan-Feb;55(1):133-6. Therapie. 2000. PMID: 10860014

6

Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Eur J Clin Pharmacol. 2000 May;56(2):181-6. doi: 10.1007/s002280050738. Eur J Clin Pharmacol. 2000. PMID: 10877014

7

Good and bad drug prescription in pregnancy.

Haramburu F, Miremont-Salamé G, Moore N. Haramburu F, et al. Among authors: moore n. Lancet. 2000 Nov 18;356(9243):1704. doi: 10.1016/S0140-6736(00)03202-5. Lancet. 2000. PMID: 11095256 No abstract available.

8

Rates of spontaneous reporting of adverse drug reactions in France.

Bégaud B, Martin K, Haramburu F, Moore N. Bégaud B, et al. Among authors: moore n. JAMA. 2002 Oct 2;288(13):1588. doi: 10.1001/jama.288.13.1588. JAMA. 2002. PMID: 12350188 No abstract available.

9

Benzodiazepine utilization patterns in Alzheimer's disease patients.

Lagnaoui R, Moore N, Moride Y, Miremont-Salamé G, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Pharmacoepidemiol Drug Saf. 2003 Sep;12(6):511-5. doi: 10.1002/pds.853. Pharmacoepidemiol Drug Saf. 2003. PMID: 14513664

10

Differences between clinical trials and postmarketing use.

Martin K, Bégaud B, Latry P, Miremont-Salamé G, Fourrier A, Moore N. Martin K, et al. Among authors: moore n. Br J Clin Pharmacol. 2004 Jan;57(1):86-92. doi: 10.1046/j.1365-2125.2003.01953.x. Br J Clin Pharmacol. 2004. PMID: 14678345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,596 results

Search Page

Filters